Skip to main navigation Skip to search Skip to main content

Immunosuppressive and nonimmunosuppressive cyclosporine analogs are toxic to the opportunistic fungal pathogen Cryptococcus neoformans via cyclophilin-dependent inhibition of calcineurin

  • M. Cristina Cruz
  • , Maurizio Del Poeta
  • , Ping Wang
  • , Roland Wenger
  • , Gerhard Zenke
  • , Valerie F.J. Quesniaux
  • , N. Rao Movva
  • , John R. Perfect
  • , Maria E. Cardenas
  • , Joseph Heitman
  • Howard Hughes Medical Institute
  • Novartis
  • Duke University

Research output: Contribution to journalArticlepeer-review

129 Scopus citations

Abstract

Cyclosporine (CsA) is an immunosuppressive and antimicrobial drug which, in complex with cyclophilin A, inhibits the protein phosphatase calcineurin. We recently found that Cryptococcus neoformans growth is resistant to CsA at 24°C but sensitive at 37°C and that calcineurin is required for growth at 37°C and pathogenicity. Here CsA analogs were screened for toxicity against C. neoformans in vitro. In most cases, antifungal activity was correlated with cyclophilin A binding in vitro and inhibition of the mixed-lymphocyte reaction and interleukin 2 production in cell culture. Two unusual nonimmunosuppressive CsA derivatives, (γ-OH) MeLeu4-Cs (211-810) and D-Sar (α-SMe)3 Val2-DH-Cs (209-825), which are also toxic to C. neoformans were identified. These CsA analogs inhibit C. neoformans via fungal cyclophilin A and calcineurin homologs. Our findings identify calcineurin as a novel antifungal drug target and suggest nonimmunosuppressive CsA analogs warrant investigation as antifungal agents.

Original languageEnglish
Pages (from-to)143-149
Number of pages7
JournalAntimicrobial Agents and Chemotherapy
Volume44
Issue number1
DOIs
StatePublished - 2000

Fingerprint

Dive into the research topics of 'Immunosuppressive and nonimmunosuppressive cyclosporine analogs are toxic to the opportunistic fungal pathogen Cryptococcus neoformans via cyclophilin-dependent inhibition of calcineurin'. Together they form a unique fingerprint.

Cite this